These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 15740097)
21. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies. Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940 [TBL] [Abstract][Full Text] [Related]
22. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Zhang ZY Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524 [TBL] [Abstract][Full Text] [Related]
23. trans-Beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases. Park J; Pei D Biochemistry; 2004 Nov; 43(47):15014-21. PubMed ID: 15554709 [TBL] [Abstract][Full Text] [Related]
24. Strategies for developing protein tyrosine phosphatase inhibitors. Tautz L; Mustelin T Methods; 2007 Jul; 42(3):250-60. PubMed ID: 17532512 [TBL] [Abstract][Full Text] [Related]
25. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z. Fukada M; Kawachi H; Fujikawa A; Noda M Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986 [TBL] [Abstract][Full Text] [Related]
26. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor. Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of protein tyrosine phosphatases PTP1B and CD45 by sulfotyrosyl peptides. Desmarais S; Jia Z; Ramachandran C Arch Biochem Biophys; 1998 Jun; 354(2):225-31. PubMed ID: 9637730 [TBL] [Abstract][Full Text] [Related]
28. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331 [TBL] [Abstract][Full Text] [Related]
29. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach. Rao GS; Ramachandran MV; Bajaj JS J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874 [TBL] [Abstract][Full Text] [Related]
30. Computational analysis of tyrosine phosphatase inhibitor selectivity for the virulence factors YopH and SptP. Hu X; Vujanac M; Stebbins CE J Mol Graph Model; 2004 Oct; 23(2):175-87. PubMed ID: 15363459 [TBL] [Abstract][Full Text] [Related]
31. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases. Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532 [TBL] [Abstract][Full Text] [Related]
32. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Zhang ZY Annu Rev Pharmacol Toxicol; 2002; 42():209-34. PubMed ID: 11807171 [TBL] [Abstract][Full Text] [Related]
33. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Welte S; Baringhaus KH; Schmider W; Müller G; Petry S; Tennagels N Anal Biochem; 2005 Mar; 338(1):32-8. PubMed ID: 15707933 [TBL] [Abstract][Full Text] [Related]
34. PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives. Cho SY; Baek JY; Han SS; Kang SK; Ha JD; Ahn JH; Lee JD; Kim KR; Cheon HG; Rhee SD; Yang SD; Yon GH; Pak CS; Choi JK Bioorg Med Chem Lett; 2006 Feb; 16(3):499-502. PubMed ID: 16289879 [TBL] [Abstract][Full Text] [Related]
35. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif. Chen YT; Seto CT Bioorg Med Chem; 2004 Jun; 12(12):3289-98. PubMed ID: 15158797 [TBL] [Abstract][Full Text] [Related]
36. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578 [TBL] [Abstract][Full Text] [Related]
37. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors. Xie J; Seto CT Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408 [TBL] [Abstract][Full Text] [Related]
38. MAPK-specific tyrosine phosphatases: new targets for drug discovery? Barr AJ; Knapp S Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785 [TBL] [Abstract][Full Text] [Related]
39. Allele-specific inhibition of divergent protein tyrosine phosphatases with a single small molecule. Zhang XY; Chen VL; Rosen MS; Blair ER; Lone AM; Bishop AC Bioorg Med Chem; 2008 Sep; 16(17):8090-7. PubMed ID: 18678493 [TBL] [Abstract][Full Text] [Related]
40. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]